The White Paper below discusses Sathguru’s estimate of the global biosimilars market size in 2030 being USD 240Bn and the current landscape with a particular emphasis on critical challenges that need to be addressed to actualize the opportunity.

Sathguru has wealth of experience and knowledge on biologics across strategy, M&A and innovation partnerships. For any comments or discussions, please reach out to the authors at or